Page last updated: 2024-08-22

1,12-dodecamethylenediamine and Glioma

1,12-dodecamethylenediamine has been researched along with Glioma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cabella, C; Colombatto, S; Grillo, MA; Heidegger, W; Hermann, A; Hochreiter, R; Langer, T; Thomas, TJ; Weiger, TM	1

Other Studies

1 other study(ies) available for 1,12-dodecamethylenediamine and Glioma

Article	Year
Long chain diamines inhibit growth of C6 glioma cells according to their hydrophobicity. An in vitro and molecular modeling study. Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 361, Issue:3 Topics: Animals; Apoptosis; Cell Cycle; Cell Division; Diamines; Dose-Response Relationship, Drug; Glioma; Models, Molecular; Ornithine Decarboxylase; Polyamines; Rats; Structure-Activity Relationship; Tumor Cells, Cultured	2000

Article

Year

Long chain diamines inhibit growth of C6 glioma cells according to their hydrophobicity. An in vitro and molecular modeling study.

Naunyn-Schmiedeberg's archives of pharmacology, 2000, Volume: 361, Issue:3

Topics: Animals; Apoptosis; Cell Cycle; Cell Division; Diamines; Dose-Response Relationship, Drug; Glioma; Models, Molecular; Ornithine Decarboxylase; Polyamines; Rats; Structure-Activity Relationship; Tumor Cells, Cultured

2000